Mizuguchi Toru, Kawamoto Masaki, Meguro Makoto, Son Seiichi, Nakamura Yukio, Harada Kohei, Shibata Toshihito, Ota Shigenori, Hirata Koichi
Department of Surgery I, Sapporo Medical University Hospital, Hokkaido, Japan.
Hepatogastroenterology. 2012 Mar-Apr;59(114):551-7. doi: 10.5754/hge10052.
BACKGROUND/AIMS: Evaluation of preoperative hepatic reserve is critical to avoid a fatal clinical course such as liver failure. We retrospectively evaluated 158 consecutive hepatocellular carcinoma (HCC) patients who underwent initial hepatectomy. The aim of this study was to determine the correlations of multiple indicators for assessment of liver function before hepatectomy. Furthermore, diagnostic probability for the pathological background and prediction of postoperative liver failure/dysfunction was compared between the antithrombin (AT) III level and indocyanine green retention rate at 15 minutes (ICGR15).
Between January 2001 and March 2008, 158 HCC patients who underwent initial hepatectomy were enrolled in this study. Spearman's correlation coefficients (r values) were obtained for 15 clinical laboratory tests including ATIII and ICGR15. Receiver operating characteristic (ROC) curve analysis was used for calculating the probability and predictive ability of the tests.
All 158 consecutive HCC patients were eligible for hepatectomy based on the Japanese guideline. ATIII is correlated with 13 of 14 other clinical tests, including albumin, bilirubin, prothrombin time, rapid turnover proteins, HGF, ICGR15 and others. The diagnostic probabilities to distinguish between normal liver and other pathological backgrounds of ATIII and ICGR15 were significantly different. The specificity of ATIII to predict postoperative liver failure/dysfunction was higher than that of ICGR15.
The serum ATIII level before hepatectomy is valuable to estimate the pathological background and predict postoperative liver failure/ dysfunction. It should be possible to use ATIII as an additional indicator for liver function and substitute for ICGR15 in the future.
背景/目的:术前评估肝脏储备功能对于避免诸如肝衰竭等致命临床病程至关重要。我们回顾性评估了158例连续接受初次肝切除术的肝细胞癌(HCC)患者。本研究的目的是确定肝切除术前评估肝功能的多个指标之间的相关性。此外,还比较了抗凝血酶(AT)III水平与15分钟吲哚菁绿滞留率(ICGR15)在病理背景诊断概率及术后肝衰竭/功能障碍预测方面的差异。
2001年1月至2008年3月期间,158例接受初次肝切除术的HCC患者纳入本研究。对包括ATIII和ICGR15在内的15项临床实验室检查获得Spearman相关系数(r值)。采用受试者操作特征(ROC)曲线分析来计算这些检查的概率和预测能力。
根据日本指南,所有158例连续的HCC患者均符合肝切除条件。ATIII与其他14项临床检查中的13项相关,包括白蛋白、胆红素、凝血酶原时间、快速周转蛋白、肝细胞生长因子、ICGR15等。ATIII和ICGR15区分正常肝脏与其他病理背景的诊断概率有显著差异。ATIII预测术后肝衰竭/功能障碍的特异性高于ICGR15。
肝切除术前血清ATIII水平对于评估病理背景及预测术后肝衰竭/功能障碍具有重要价值。未来有可能将ATIII用作肝功能的额外指标并替代ICGR15。